Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haixia Ding

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Pharmacy|April 15, 2026
Cost-effectiveness of toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China and the United States healthcare systemsJunhao Yang, Haixia Ding
Biology|June 26, 2025
Osthole: A Coumarin with Dual Roles in Biology and ChemistryMin Lv, Haixia Ding, Hui Xu
International Journal of Clinical Pharmacy|July 24, 2025
Cost-effectiveness of benmelstobart-anlotinib-chemotherapy in extensive-stage small-cell lung cancer: A comparative analysis across United States and Chinese healthcare systemsJunjie Wan, Yizhou Xu, Bin Wan, et al.
Plant Disease|October 20, 2022
Complete Genome Sequence of <i>Bacillus velezensis</i> GUAL210, a Potential Biocontrol Agent Isolated from Pepper RhizosphereZhicheng Zhou, Xianying Tang, Lijuan Peng, et al.
Breast Cancer Research and Treatment|February 5, 2010
COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studiesHaixia Ding, Yuanyuan Fu, Weixian Chen, et al.
Breast Cancer Research and Treatment|April 17, 2010
RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjectsZhanwei Wang, Hairong Dong, Yuanyuan Fu, et al.
Frontiers in Health Services|September 15, 2025
A multi-stakeholder multicriteria decision analysis for implantable medical devices assessment in ChinaYizhou Xu, Junjie Wan, Bin Wan, et al.
Frontiers in Health Services|October 6, 2025
Correction: A multi-stakeholder multicriteria decision analysis for implantable medical devices assessment in ChinaYizhou Xu, Junjie Wan, Bin Wan, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2018
Associations of genetic polymorphisms of the vitamin D pathway with blood pressure in a Han Chinese populationXiaoman Ye, Jian Jia, Ning Zhang, et al.
Molecular Plant Pathology|April 29, 2023
Phospholipase C: Diverse functions in plant biotic stress resistance and fungal pathogenicityYuanpeng Fang, Junmei Jiang, Haixia Ding, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Pharmacy|April 15, 2026
Cost-effectiveness of toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China and the United States healthcare systemsJunhao Yang, Haixia Ding
Biology|June 26, 2025
Osthole: A Coumarin with Dual Roles in Biology and ChemistryMin Lv, Haixia Ding, Hui Xu
International Journal of Clinical Pharmacy|July 24, 2025
Cost-effectiveness of benmelstobart-anlotinib-chemotherapy in extensive-stage small-cell lung cancer: A comparative analysis across United States and Chinese healthcare systemsJunjie Wan, Yizhou Xu, Bin Wan, et al.
Plant Disease|October 20, 2022
Complete Genome Sequence of <i>Bacillus velezensis</i> GUAL210, a Potential Biocontrol Agent Isolated from Pepper RhizosphereZhicheng Zhou, Xianying Tang, Lijuan Peng, et al.
Breast Cancer Research and Treatment|February 5, 2010
COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studiesHaixia Ding, Yuanyuan Fu, Weixian Chen, et al.
Breast Cancer Research and Treatment|April 17, 2010
RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjectsZhanwei Wang, Hairong Dong, Yuanyuan Fu, et al.
Frontiers in Health Services|September 15, 2025
A multi-stakeholder multicriteria decision analysis for implantable medical devices assessment in ChinaYizhou Xu, Junjie Wan, Bin Wan, et al.
Frontiers in Health Services|October 6, 2025
Correction: A multi-stakeholder multicriteria decision analysis for implantable medical devices assessment in ChinaYizhou Xu, Junjie Wan, Bin Wan, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2018
Associations of genetic polymorphisms of the vitamin D pathway with blood pressure in a Han Chinese populationXiaoman Ye, Jian Jia, Ning Zhang, et al.
Molecular Plant Pathology|April 29, 2023
Phospholipase C: Diverse functions in plant biotic stress resistance and fungal pathogenicityYuanpeng Fang, Junmei Jiang, Haixia Ding, et al.
Pageof 10